Dr. Song, Managing Director of LISCure, worked as a postdoc and instructor at Tulane University, School of Medicine, researching liver cancer and nonalcoholic steatohepatitis. He led the research and development of drugs for NASH and autoimmune diseases in the clinical stage by conducting research on the mechanism and efficacy of candidate substances and preclinical experiments at LISCure. He plays an important role in LISCure’s lab as well as global partnerships with Mayo Clinic and Scripps Labs.